What does CUSIP 00972D105 represent in this 13F holders report?

CUSIP 00972D105 is the security identifier for AKBA - Akebia Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AKBA - Akebia Therapeutics, Inc. - Common Stock in Q2 2022?

82 institutional investors reported AKBA - Akebia Therapeutics, Inc. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Akebia Therapeutics, Inc. - Common Stock (AKBA)

CUSIP: 00972D105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 263,222,327
Total 13F shares: 57,164,176
Share change: -23,577,858
Total reported value: $20,180,226
Put/Call ratio: 49%
Price per share: $0.35
Number of holders: 82
Value change: -$11,164,741
Number of buys: 36
Number of sells: 81

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 00972D105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	5.5%	14,402,988	$10,339,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	5.3%	13,960,995	$10,023,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	4.4%	11,488,224	$8,247,000	—	31 Mar 2022	13F
Alerce Investment Management, L.P.	13F	Company	1.8%	4,652,561	$3,340,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	1.6%	4,258,011	$3,057,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	3,152,758	$2,263,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1%	2,666,861	$1,915,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1%	2,631,814	$1,889,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	0.77%	2,030,015	$1,457,000	—	31 Mar 2022	13F
Orchard Capital Management, LLC	13F	Company	0.67%	1,762,731	$1,265,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.64%	1,675,484	$1,203,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.38%	1,003,327	$720,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.38%	995,041	$714,000	—	31 Mar 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.37%	984,741	$707,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.34%	900,967	$647,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.29%	769,438	$553,000	—	31 Mar 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.27%	702,647	$504,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.24%	638,883	$459,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.21%	550,647	$395,000	—	31 Mar 2022	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.2%	513,292	$368,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.18%	485,284	$348,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.18%	476,974	$343,000	—	31 Mar 2022	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.18%	471,681	$339,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.17%	454,997	$326,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.15%	404,233	$290,000	—	31 Mar 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.15%	402,184	$289,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.15%	393,085	$282,000	—	31 Mar 2022	13F
Violetta Cotreau	3/4/5	SVP, Chief Accounting Officer	— class O/S missing	219,954	$268,982	—	12 May 2022	3/4/5
Allspring Global Investments Holdings, LLC	13F	Company	0.13%	349,652	$251,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.13%	339,449	$244,000	—	31 Mar 2022	13F
CREDIT SUISSE AG/	13F	Company	0.12%	324,710	$233,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.12%	316,863	$227,000	—	31 Mar 2022	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.12%	309,569	$222,000	—	31 Mar 2022	13F
Dell J. Faulkingham	3/4/5	SVP, CCO	— mixed-class rows	373,841 mixed-class rows	$212,590	—	28 Feb 2022	3/4/5
WELLS FARGO & COMPANY/MN	13F	Company	0.11%	295,633	$212,000	—	31 Mar 2022	13F
STRS OHIO	13F	Company	0.11%	285,500	$204,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.11%	279,958	$201,000	—	31 Mar 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.1%	255,967	$182,000	—	31 Mar 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.1%	250,894	$180,000	—	31 Mar 2022	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.09%	249,912	$177,000	—	31 Mar 2022	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.09%	246,300	$177,000	—	31 Mar 2022	13F
CITIGROUP INC	13F	Company	0.09%	236,790	$170,000	—	31 Mar 2022	13F
ExodusPoint Capital Management, LP	13F	Company	0.09%	224,537	$161,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	0.09%	224,001	$161,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.08%	215,881	$155,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.08%	205,062	$147,000	—	31 Mar 2022	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.07%	184,939	$132,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.07%	184,465	$132,000	—	31 Mar 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.07%	180,790	$129,790	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.06%	150,335	$108,000	—	31 Mar 2022	13F

Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2022

As of 30 Jun 2022, Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,164,176 shares. The largest 10 holders included VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, SATTER MANAGEMENT CO., L.P., BlackRock Inc., FEDERATED HERMES, INC., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, HRT FINANCIAL LP, and AQR CAPITAL MANAGEMENT LLC. This page lists 82 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

115

Q2 2022 holders

Holder diff

-33

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.